Temazepam can cause developmental toxicity according to state or federal government labeling requirements. Temazepam is a benzodiazepine. Temazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. It is grouped under the following drug class(es): Benzodiazepines, Hypnotics, Neurotransmitter agents, Psychotropic agents, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as antianxiety drugs, central nervous system (CNS) agents, sleeping drugs and veterinary tranquilizers. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Restoril, Hydroxydiazepam, Methyloxazepam and Oxydiazepam. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 5391.
Temazepam
| CAS No | 846-50-4 |
|---|---|
| Molecular Formula | C16H13ClN2O2 |
| Molecular Weight | 300.74 g/mol |
| Synonyms | 7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Temazepam can cause developmental toxicity according to state or federal government labeling requirements. Temazepam is a benzodiazepine. Temazepam is a DEA Schedule IV controlled substance.
The listed CAS number is 846-50-4.
The listed molecular formula is C16H13ClN2O2.
The listed molecular weight is 300.74 g/mol.
7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one.
The source lists Restoril, Hydroxydiazepam, Methyloxazepam and Oxydiazepam.